Trust Size
$478M
What Happened
Point Biopharma Global Inc. filed its S-1 registration in 2020. The company was delisted from exchanges with 285 SEC filings on record.
Point Biopharma Global Inc. entered the SPAC market in 2020 with its initial S-1 filing with the SEC, joining the wave of blank check companies seeking acquisition targets.
SEC records show 285 total filings, including annual (10-K) and quarterly (10-Q) financial reports.
The company's last SEC filing was 2024-01-08, and it appears to have been delisted from exchanges — a common fate for SPACs that fail to meet listing requirements or generate sufficient shareholder interest.
Timeline
2020-07-07
S-1 Registration Filed
2024-01-08
Last SEC Filing
📄 SEC Filings
View all EDGAR filings for Point Biopharma Global